- O O O O
[Medicines](../../Medicines/medicines-landing.asp) O O O O
[Devices](../../devices/devices-landing.asp) O O O O
[Safety](../safety-landing.asp) O O O O
Alert O O O O
communication O O O O
Myocarditis O O O O
and O O O O
pericarditis O O O O
- O O O O
rare O O O O
adverse O O O O
reactions O O O O
to O O O O
Comirnaty O O O O
(Pfizer O O O O
COVID-19 O O O O
vaccine) O O O O
21 O O O O
July O O O O
2021 O O O O
On O O O O
9 O O O O
June O O O O
2021 O O O O
we O O O O
published O O O O
a O O O O
[Monitoring O O O O
Communication](comirnaty-myocarditis.asp) O O O O
on O O O O
a O O O O
safety O O O O
signal O O O O
of O O O O
myocarditis O O O O
with O O O O
Comirnaty O O O O
vaccine. O O O O
It O O O O
has O O O O
now O O O O
been O O O O
concluded O O O O
by O O O O
Medsafe, O O O O
other O O O O
national O O O O
regulators O O O O
(such O O O O
as O O O O
the O O O O
FDA) O O O O
and O O O O
the O O O O
company, O O O O
Pfizer, O O O O
that O O O O
myocarditis O O O O
(inflammation O O O O
of O O O O
the O O O O
heart O O O O
muscle) O O O O
is O O O O
a O O O O
rare O O O O
side O O O O
effect O O O O
of O O O O
vaccination O O O O
with O O O O
Comirnaty. O O O O
As O O O O
it O O O O
is O O O O
sometimes O O O O
difficult O O O O
to O O O O
distinguish O O O O
between O O O O
myocarditis O O O O
and O O O O
pericarditis O O O O
(inflammation O O O O
of O O O O
the O O O O
sac O O O O
surrounding O O O O
the O O O O
heart), O O O O
the O O O O
warning O O O O
will O O O O
relate O O O O
to O O O O
both O O O O
conditions. O O O O
This O O O O
information O O O O
will O O O O
be O O O O
added O O O O
to O O O O
the O O O O
data O O O O
sheet O O O O
very O O O O
shortly. O O O O
The O O O O
wording O O O O
will O O O O
be O O O O
similar O O O O
to O O O O
the O O O O
update O O O O
recently O O O O
made O O O O
in O O O O
the O O O O
United O O O O
Kingdom: O O O O
There O O O O
have O O O O
been O O O O
very O O O O
rare O O O O
reports O O O O
of O O O O
myocarditis O O O O
and O O O O
pericarditis O O O O
occurring O O O O
after O O O O
vaccination O O O O
with O O O O
Comirnaty O O O O
often O O O O
in O O O O
younger O O O O
men O O O O
and O O O O
shortly O O O O
after O O O O
the O O O O
second O O O O
dose O O O O
of O O O O
the O O O O
vaccine. O O O O
These O O O O
are O O O O
typically O O O O
mild O O O O
cases O O O O
and O O O O
individuals O O O O
tend O O O O
to O O O O
recover O O O O
within O O O O
a O O O O
short O O O O
time O O O O
following O O O O
standard O O O O
treatment O O O O
and O O O O
rest. O O O O
Healthcare O O O O
professionals O O O O
should O O O O
be O O O O
alert O O O O
to O O O O
the O O O O
signs O O O O
and O O O O
symptoms O O O O
of O O O O
myocarditis O O O O
and O O O O
pericarditis. O O O O
Vaccinated O O O O
individuals O O O O
should O O O O
also O O O O
seek O O O O
immediate O O O O
medical O O O O
attention O O O O
should O O O O
they O O O O
experience O O O O
new O O O O
onset O O O O
of O O O O
chest O O O O
pain, O O O O
shortness O O O O
of O O O O
breath, O O O O
palpitations O O O O
or O O O O
arrhythmias. O O O O
Myocarditis O O O O
has O O O O
also O O O O
been O O O O
seen O O O O
in O O O O
relation O O O O
to O O O O
COVID-19 O O O O
infection. O O O O
[Advice O O O O
for O O O O
consumers O O O O
and O O O O
Advice O O O O
for O O O O
consumers O O O O
and O O O O
caregivers O O O O
- O O O O
In O O O O
the O O O O
first O O O O
few O O O O
days O O O O
after O O O O
your O O O O
vaccination O O O O
seek O O O O
medical O O O O
attention O O O O
if O O O O
you O O O O
experience O O O O
new O O O O
onset O O O O
chest O O O O
pain, O O O O
shortness O O O O
of O O O O
breath O O O O
or O O O O
an O O O O
abnormal O O O O
heartbeat. O O O O
These O O O O
are O O O O
potential O O O O
signs O O O O
of O O O O
myocarditis. O O O O
- O O O O
Myocarditis O O O O
has O O O O
affected O O O O
less O O O O
than O O O O
one O O O O
person O O O O
in O O O O
a O O O O
million O O O O
people O O O O
who O O O O
have O O O O
had O O O O
Comirnaty O O O O
vaccine O O O O
in O O O O
the O O O O
European O O O O
Union O O O O
countries. O O O O
[3](#references)In O O O O
most O O O O
cases O O O O
the O O O O
myocarditis O O O O
was O O O O
mild O O O O
and O O O O
is O O O O
not O O O O
expected O O O O
to O O O O
have O O O O
any O O O O
long-term O O O O
effects. O O O O
- O O O O
Comirnaty O O O O
COVID-19 O O O O
vaccine O O O O
is O O O O
highly O O O O
effective O O O O
in O O O O
protecting O O O O
people O O O O
from O O O O
COVID-19 O O O O
infection, O O O O
which O O O O
can O O O O
also O O O O
cause O O O O
myocarditis O O O O
[Please O O O O
report O O O O
any O O O O
adverse O O O O
event O O O O
following O O O O
immunisation O O O O
with O O O O
COVID-19 O O O O
vaccine O O O O
to O O O O
CARM](https://report.vaccine.covid19.govt.nz/s/) O O O O
Information O O O O
for O O O O
healthcare O O O O
professionals O O O O
- O O O O
Myocarditis O O O O
has O O O O
been O O O O
determined O O O O
to O O O O
be O O O O
a O O O O
rare O O O O
side O O O O
effect O O O O
(less O O O O
than O O O O
1 O O O O
in O O O O
a O O O O
million O O O O
overall O O O O
[3](#references)) O O O O
to O O O O
vaccination O O O O
with O O O O
Comirnaty. O O O O
This O O O O
information O O O O
will O O O O
be O O O O
added O O O O
to O O O O
the O O O O
data O O O O
sheet O O O O
very O O O O
shortly. O O O O
- O O O O
Be O O O O
alert O O O O
to O O O O
the O O O O
signs O O O O
and O O O O
symptoms O O O O
of O O O O
myocarditis O O O O
and O O O O
pericarditis O O O O
occurring O O O O
in O O O O
people O O O O
after O O O O
vaccination. O O O O
- O O O O
Vaccinated O O O O
individuals O O O O
should O O O O
be O O O O
advised O O O O
to O O O O
seek O O O O
immediate O O O O
medical O O O O
attention O O O O
should O O O O
they O O O O
experience O O O O
new O O O O
onset O O O O
of O O O O
chest O O O O
pain, O O O O
shortness O O O O
of O O O O
breath, O O O O
palpitations O O O O
or O O O O
arrhythmias. O O O O
- O O O O
There O O O O
is O O O O
no O O O O
contraindication O O O O
or O O O O
change O O O O
to O O O O
the O O O O
vaccination O O O O
schedule O O O O
required O O O O
for O O O O
the O O O O
first O O O O
or O O O O
second O O O O
dose O O O O
of O O O O
the O O O O
vaccine O O O O
for O O O O
anyone O O O O
who O O O O
has O O O O
experienced O O O O
myocarditis O O O O
in O O O O
the O O O O
data O O O O
sheet O O O O
update. O O O O
However, O O O O
a O O O O
decision O O O O
to O O O O
vaccinate O O O O
should O O O O
be O O O O
made O O O O
with O O O O
the O O O O
individual O O O O
after O O O O
full O O O O
consideration O O O O
of O O O O
their O O O O
circumstances. O O O O
- O O O O
Globally, O O O O
the O O O O
rate O O O O
appears O O O O
to O O O O
be O O O O
highest O O O O
in O O O O
younger O O O O
men O O O O
(aged O O O O
18-24 O O O O
years) O O O O
and O O O O
after O O O O
the O O O O
second O O O O
dose. O O O O
The O O O O
rate O O O O
estimated O O O O
from O O O O
confirmed O O O O
cases O O O O
in O O O O
health O O O O
databases O O O O
in O O O O
the O O O O
USA O O O O
was O O O O
8 O O O O
per O O O O
million O O O O
for O O O O
12-39 O O O O
year O O O O
olds O O O O
after O O O O
dose O O O O
2 O O O O
(the O O O O
estimated O O O O
rate O O O O
with O O O O
the O O O O
Moderna O O O O
vaccine O O O O
was O O O O
higher O O O O
in O O O O
this O O O O
analysis). O O O O
[4](#references)Myocarditis O O O O
occurred O O O O
mostly O O O O
within O O O O
4 O O O O
days O O O O
but O O O O
in O O O O
a O O O O
few O O O O
cases O O O O
up O O O O
to O O O O
14 O O O O
days O O O O
after O O O O
vaccination. O O O O
- O O O O
To O O O O
date, O O O O
CARM O O O O
and O O O O
Medsafe O O O O
have O O O O
received O O O O
reports O O O O
for O O O O
people O O O O
across O O O O
a O O O O
wide O O O O
range O O O O
of O O O O
ages. O O O O
Some O O O O
of O O O O
the O O O O
reports O O O O
of O O O O
myocarditis O O O O
were O O O O
in O O O O
women O O O O
and/or O O O O
occurred O O O O
after O O O O
the O O O O
first O O O O
dose. O O O O
- O O O O
Myocarditis O O O O
following O O O O
Comirnaty O O O O
vaccination O O O O
is O O O O
usually O O O O
mild, O O O O
and O O O O
individuals O O O O
have O O O O
tended O O O O
to O O O O
recover O O O O
within O O O O
a O O O O
short O O O O
time O O O O
following O O O O
standard O O O O
treatment O O O O
and O O O O
rest. O O O O
- O O O O
Myocarditis O O O O
after O O O O
vaccination O O O O
should O O O O
be O O O O
treated O O O O
as O O O O
usual. O O O O
Consult O O O O
applicable O O O O
guidance O O O O
and/or O O O O
consult O O O O
specialists O O O O
(eg, O O O O
cardiologists) O O O O
if O O O O
needed O O O O
for O O O O
more O O O O
information O O O O
on O O O O
management. O O O O
[Please O O O O
continue O O O O
to O O O O
report O O O O
adverse O O O O
events O O O O
following O O O O
immunisation O O O O
with O O O O
COVID-19 O O O O
vaccines O O O O
to O O O O
CARM](https://report.vaccine.covid19.govt.nz/s/) O O O O
Product O O O O
affected O O O O
|Product O O O O
name||Sponsor| O O O O
|Comirnaty||Pfizer O O O O
BioNTech| O O O O
Further O O O O
information O O O O
Myocarditis Reason 3 O O
is Reason 3 O O
inflammation Reason 3 O O
of Reason 3 O O
the Reason 3 O O
heart Reason 3 O O
muscle, Reason 3 O O
while Reason 3 O O
the Reason 3 O O
tissue Reason 3 O O
forming Reason 3 O O
a Reason 3 O O
sac Reason 3 O O
around Reason 3 O O
the Reason 3 O O
heart Reason 3 O O
is Reason 3 O O
inflamed Reason 3 O O
in Reason 3 O O
pericarditis. Reason 3 O O
Myo-pericarditis Reason 3 O O
means Reason 3 O O
that Reason 3 O O
both Reason 3 O O
the Reason 3 O O
heart Reason 3 O O
muscle Reason 3 O O
and Reason 3 O O
the Reason 3 O O
sac Reason 3 O O
are Reason 3 O O
inflamed. Reason 3 O O
There Reason 3 O O
are Reason 3 O O
many Reason 3 O O
possible Reason 3 O O
causes Reason 3 O O
of Reason 3 O O
myocarditis, Reason 3 O O
the Reason 3 O O
most Reason 3 O O
common Reason 3 O O
being Reason 3 O O
viral Reason 3 O O
infection. Reason 3 O O
Over Reason 3 O O
100 Reason 3 O O
people Reason 3 O O
are Reason 3 O O
discharged Reason 3 O O
from Reason 3 O O
hospital Reason 3 O O
with Reason 3 O O
a Reason 3 O O
principle Reason 3 O O
diagnosis Reason 3 O O
of Reason 3 O O
myocarditis Reason 3 O O
in Reason 3 O O
New Reason 3 O O
Zealand Reason 3 O O
every Reason 3 O O
year. Reason 3 O O
It Reason 3 O O
has Reason 3 O O
been Reason 3 O O
shown Reason 3 O O
that Reason 3 O O
men Reason 3 O O
are Reason 3 O O
three Reason 3 O O
times Reason 3 O O
more Reason 3 O O
susceptible Reason 3 O O
to Reason 3 O O
myocarditis Reason 3 O O
than Reason 3 O O
women. Reason 3 O O
Young Reason 3 O O
men Reason 3 O O
(aged Reason 3 O O
16-20 Reason 3 O O
years) Reason 3 O O
are Reason 3 O O
especially Reason 3 O O
at Reason 3 O O
risk Reason 3 O O
of Reason 3 O O
experiencing Reason 3 O O
myocarditis, Reason 3 O O
while Reason 3 O O
women Reason 3 O O
are Reason 3 O O
affected Reason 3 O O
most Reason 3 O O
after Reason 3 O O
menopause. Reason 3 O O
[5](#references) Reason 3 O O
The Reason 3 O O
estimated Reason 3 O O
rate Reason 3 O O
of Reason 3 O O
hospitalisation Reason 3 O O
due Reason 3 O O
to Reason 3 O O
myocarditis Reason 3 O O
in Reason 3 O O
New Reason 3 O O
Zealand Reason 3 O O
is Reason 3 O O
around Reason 3 O O
2 Reason 3 O O
per Reason 3 O O
100,000 Reason 3 O O
person Reason 3 O O
years Reason 3 O O
(Interim Reason 3 O O
data Reason 3 O O
SAFE Reason 3 O O
study Reason 3 O O
led Reason 3 O O
by Reason 3 O O
Associate Reason 3 O O
Professor Reason 3 O O
Helen Reason 3 O O
Petousis-Harris, Reason 3 O O
University Reason 3 O O
of Reason 3 O O
Auckland). Reason 3 O O
Myocarditis Reason 3 O O
has Reason 3 O O
been Reason 3 O O
seen Reason 3 O O
in Reason 3 O O
relation Reason 3 O O
to Reason 3 O O
Covid Reason 3 O O
19 Reason 3 O O
infection. Reason 3 O O
The Reason 3 O O
short- Reason 3 O O
and Reason 3 O O
long-term Reason 3 O O
implications Reason 3 O O
of Reason 3 O O
SARS Reason 3 O O
CoV-2 Reason 3 O O
infection-induced Reason 3 O O
myocarditis Reason 3 O O
are Reason 3 O O
being Reason 3 O O
monitored. Reason 3 O O
[6](#references) Reason 3 O O
The Reason 3 O O
United Reason 3 O O
States Reason 3 O O
was Reason 3 O O
among Reason 3 O O
the Reason 3 O O
first Reason 3 O O
countries Reason 3 O O
starting Reason 3 O O
to Reason 3 O O
vaccinate Reason 3 O O
people Reason 3 O O
from Reason 3 O O
12 Reason 3 O O
years Reason 3 O O
of Reason 3 O O
age Reason 3 O O
with Reason 3 O O
Comirnaty. Reason 3 O O
Currently Reason 3 O O
the Reason 3 O O
rate Reason 3 O O
estimated Reason 3 O O
from Reason 3 O O
confirmed Reason 3 O O
cases Reason 3 O O
in Reason 3 O O
health Reason 3 O O
databases Reason 3 O O
in Reason 3 O O
the Reason 3 O O
USA Reason 3 O O
was Reason 3 O O
8 Reason 3 O O
per Reason 3 O O
million Reason 3 O O
for Reason 3 O O
12-39 Reason 3 O O
year Reason 3 O O
olds Reason 3 O O
after Reason 3 O O
dose Reason 3 O O
2. Reason 3 O O
The Reason 3 O O
rate Reason 3 O O
was Reason 3 O O
higher Reason 3 O O
at Reason 3 O O
23 Reason 3 O O
cases Reason 3 O O
per Reason 3 O O
million Reason 3 O O
in Reason 3 O O
12-39 Reason 3 O O
year Reason 3 O O
olds Reason 3 O O
when Reason 3 O O
unconfirmed Reason 3 O O
cases Reason 3 O O
were Reason 3 O O
included Reason 3 O O
in Reason 3 O O
the Reason 3 O O
estimate Reason 3 O O
(this Reason 3 O O
rate Reason 3 O O
was Reason 3 O O
in Reason 3 O O
males, Reason 3 O O
there Reason 3 O O
were Reason 3 O O
no Reason 3 O O
cases Reason 3 O O
reported Reason 3 O O
in Reason 3 O O
females). Reason 3 O O
[4](#references) Reason 3 O O
The Reason 3 O O
overall Reason 3 O O
rate Reason 3 O O
across Reason 3 O O
all Reason 3 O O
ages Reason 3 O O
and Reason 3 O O
both Reason 3 O O
sexes Reason 3 O O
currently Reason 3 O O
remains Reason 3 O O
at Reason 3 O O
less Reason 3 O O
than Reason 3 O O
1 Reason 3 O O
in Reason 3 O O
a Reason 3 O O
million Reason 3 O O
[3](#references). Reason 3 O O
Myocarditis Reason 3 O O
and Reason 3 O O
pericarditis Reason 3 O O
reactions Reason 3 O O
have Reason 3 O O
also Reason 3 O O
been Reason 3 O O
reported Reason 3 O O
for Reason 3 O O
other Reason 3 O O
COVID-19 Reason 3 O O
vaccines, Reason 3 O O
such Reason 3 O O
as Reason 3 O O
Moderna, Reason 3 O O
and Reason 3 O O
to Reason 3 O O
a Reason 3 O O
much Reason 3 O O
lesser Reason 3 O O
extent Reason 3 O O
AstraZeneca Reason 3 O O
and Reason 3 O O
Janssen Reason 3 O O
vaccines. Reason 3 O O
Up Reason 3 O O
to Reason 3 O O
19 Reason 3 O O
July Reason 3 O O
2021, Reason 3 O O
the Reason 3 O O
Centre Reason 3 O O
for Reason 3 O O
Adverse Reason 3 O O
Reactions Reason 3 O O
Monitoring Reason 3 O O
(CARM) Reason 3 O O
has Reason 3 O O
received Reason 3 O O
9 Reason 3 O O
cases Reason 3 O O
of Reason 3 O O
myocarditis, Reason 3 O O
5 Reason 3 O O
cases Reason 3 O O
of Reason 3 O O
pericarditis Reason 3 O O
and Reason 3 O O
4 Reason 3 O O
cases Reason 3 O O
of Reason 3 O O
myopericarditis. Reason 3 O O
Eight Reason 3 O O
of Reason 3 O O
the Reason 3 O O
cases Reason 3 O O
involved Reason 3 O O
male Reason 3 O O
vaccinees. Reason 3 O O
Not Reason 3 O O
all Reason 3 O O
the Reason 3 O O
cases Reason 3 O O
reported Reason 3 O O
to Reason 3 O O
date Reason 3 O O
were Reason 3 O O
admitted Reason 3 O O
to Reason 3 O O
hospital. Reason 3 O O
Cases Reason 3 O O
reported Reason 3 O O
to Reason 3 O O
CARM Reason 3 O O
are Reason 3 O O
being Reason 3 O O
reviewed Reason 3 O O
by Reason 3 O O
the Reason 3 O O
Independent Reason 3 O O
Safety Reason 3 O O
Monitoring Reason 3 O O
Board. Reason 3 O O
To Reason 3 O O
date Reason 3 O O
there Reason 3 O O
has Reason 3 O O
been Reason 3 O O
no Reason 3 O O
clear Reason 3 O O
increase Reason 3 O O
in Reason 3 O O
cases Reason 3 O O
of Reason 3 O O
myocarditis Reason 3 O O
in Reason 3 O O
New Reason 3 O O
Zealand. Reason 3 O O
The Reason 3 O O
age Reason 3 O O
ranges Reason 3 O O
are Reason 3 O O
shown Reason 3 O O
in Reason 3 O O
Figure Reason 3 O O
1. Reason 3 O O
Figure Reason 3 O O
1: Reason 3 O O
Ages Reason 3 O O
of Reason 3 O O
people Reason 3 O O
reported Reason 3 O O
with Reason 3 O O
myocarditis/pericarditis Reason 3 O O
after Reason 3 O O
vaccination Reason 3 O O
in Reason 3 O O
New Reason 3 O O
Zealand Reason 3 O O
* Reason 3 O O
these Reason 3 O O
reports Reason 3 O O
do Reason 3 O O
not Reason 3 O O
necessarily Reason 3 O O
have Reason 3 O O
a Reason 3 O O
causal Reason 3 O O
relationship Reason 3 O O
with Reason 3 O O
administration Reason 3 O O
of Reason 3 O O
Comirnaty Reason 3 O O
and Reason 3 O O
may Reason 3 O O
represent Reason 3 O O
coincidental Reason 3 O O
events. Reason 3 O O
Five Reason 3 O O
of Reason 3 O O
the Reason 3 O O
reported Reason 3 O O
reactions Reason 3 O O
occurred Reason 3 O O
after Reason 3 O O
the Reason 3 O O
first Reason 3 O O
dose Reason 3 O O
and Reason 3 O O
13 Reason 3 O O
occurred Reason 3 O O
after Reason 3 O O
the Reason 3 O O
second Reason 3 O O
dose. Reason 3 O O
[The Reason 3 O O
New Reason 3 O O
Zealand Reason 3 O O
data Reason 3 O O
sheet Reason 3 O O
for Reason 3 O O
Comirnaty](../../profs/Datasheet/c/comirnatyinj.pdf) Reason 3 O O
will Reason 3 O O
be Reason 3 O O
updated Reason 3 O O
shortly Reason 3 O O
with Reason 3 O O
a Reason 3 O O
myocarditis Reason 3 O O
and Reason 3 O O
pericarditis Reason 3 O O
warning Reason 3 O O
and Reason 3 O O
precaution. Reason 3 O O
Medsafe Reason 3 O O
will Reason 3 O O
continue Reason 3 O O
to Reason 3 O O
monitor Reason 3 O O
this Reason 3 O O
adverse Reason 3 O O
reaction Reason 3 O O
to Reason 3 O O
Comirnaty Reason 3 O O
to Reason 3 O O
ensure Reason 3 O O
we Reason 3 O O
have Reason 3 O O
identified Reason 3 O O
risk Reason 3 O O
factors Reason 3 O O
and Reason 3 O O
outcomes Reason 3 O O
for Reason 3 O O
anyone Reason 3 O O
affected. Reason 3 O O
Useful Reason 3 O O
links Reason 3 O O
[Search Reason 3 O O
for Reason 3 O O
consumer Reason 3 O O
medicine Reason 3 O O
information Reason 3 O O
(CMI) Reason 3 O O
and Reason 3 O O
data Reason 3 O O
sheets](../../Medicines/infoSearch.asp) Reason 3 O O
[Monitoring Reason 3 O O
communication](comirnaty-myocarditis.asp) Reason 3 O O
[Report Reason 3 O O
an Reason 3 O O
adverse Reason 3 O O
reaction Reason 3 O O
to Reason 3 O O
a Reason 3 O O
medicine](https://nzphvc.otago.ac.nz/reporting/) Reason 3 O O
References Reason 3 O O
- Reason 3 O O
Medicine Reason 3 O O
& Reason 3 O O
Healthcare Reason 3 O O
products Reason 3 O O
Regulatory Reason 3 O O
Agency. Reason 3 O O
2021. Reason 3 O O
Information Reason 3 O O
for Reason 3 O O
healthcare Reason 3 O O
professionals Reason 3 O O
on Reason 3 O O
COVID-19 Reason 3 O O
vaccine Reason 3 O O
Pfizer/BioNTech Reason 3 O O
(Regulation Reason 3 O O
174) Reason 3 O O
9 Reason 3 O O
July Reason 3 O O
2021. Reason 3 O O
URL: Reason 3 O O
[https://www.gov.uk/government/publications/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19/information-for-healthcare-professionals-on-pfizerbiontech-covid-19-vaccine](https://www.gov.uk/government/publications/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19/information-for-healthcare-professionals-on-pfizerbiontech-covid-19-vaccine)(accessed Reason 3 O O
19 Reason 3 O O
July Reason 3 O O
2021). Reason 3 O O
- Reason 3 O O
Centers Reason 3 O O
for Reason 3 O O
Disease Reason 3 O O
Control Reason 3 O O
and Reason 3 O O
Prevention. Reason 3 O O
2021. Reason 3 O O
Use Reason 3 O O
of Reason 3 O O
mRNA Reason 3 O O
COVID-19 Reason 3 O O
vaccine Reason 3 O O
after Reason 3 O O
reports Reason 3 O O
of Reason 3 O O
myocarditis Reason 3 O O
among Reason 3 O O
vaccine Reason 3 O O
recipients: Reason 3 O O
Update Reason 3 O O
from Reason 3 O O
the Reason 3 O O
Advisory Reason 3 O O
Committee Reason 3 O O
on Reason 3 O O
Immunization Reason 3 O O
Practices Reason 3 O O
— Reason 3 O O
United Reason 3 O O
States, Reason 3 O O
June Reason 3 O O
2021. Reason 3 O O
MMWR Reason 3 O O
70(27): Reason 3 O O
977-82. Reason 3 O O
URL: Reason 3 O O
[https://www.cdc.gov/mmwr/volumes/70/wr/pdfs/mm7027e2-H.pdf](https://www.cdc.gov/mmwr/volumes/70/wr/pdfs/mm7027e2-H.pdf)(accessed Reason 3 O O
Medicines Reason 3 O O
Agency. Reason 3 O O
Comirnaty Reason 3 O O
and Reason 3 O O
Spikevax: Reason 3 O O
possible Reason 3 O O
link Reason 3 O O
to Reason 3 O O
very Reason 3 O O
rare Reason 3 O O
cases Reason 3 O O
of Reason 3 O O
myocarditis Reason 3 O O
and Reason 3 O O
pericarditis Reason 3 O O
9 Reason 3 O O
July Reason 3 O O
2021. Reason 3 O O
URL: Reason 3 O O
[https://www.ema.europa.eu/en/news/comirnaty-spikevax-possible-link-very-rare-cases-myocarditis-pericarditis](https://www.ema.europa.eu/en/news/comirnaty-spikevax-possible-link-very-rare-cases-myocarditis-pericarditis)(accessed Reason 3 O O
19 Reason 3 O O
July Reason 3 O O
2021). Reason 3 O O
- Reason 3 O O
Shimabukuro, Reason 3 O O
T. Reason 3 O O
vaccine Reason 3 O O
safety Reason 3 O O
updates Reason 3 O O
23 Reason 3 O O
June Reason 3 O O
2021. Reason 3 O O
URL: Reason 3 O O
[https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2021-06/03-COVID-Shimabukuro-508.pdf](https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2021-06/03-COVID-Shimabukuro-508.pdf)(accessed Reason 3 O O
19 Reason 3 O O
July Reason 3 O O
2021). Reason 3 O O
- Reason 3 O O
Kytö Reason 3 O O
V, Reason 3 O O
Sipilä Reason 3 O O
J, Reason 3 O O
Rautava Reason 3 O O
P. Reason 3 O O
2013. Reason 3 O O
The Reason 3 O O
effects Reason 3 O O
of Reason 3 O O
gender Reason 3 O O
and Reason 3 O O
age Reason 3 O O
on Reason 3 O O
occurrence Reason 3 O O
of Reason 3 O O
clinically Reason 3 O O
suspected Reason 3 O O
myocarditis Reason 3 O O
in Reason 3 O O
adulthood. Reason 3 O O
Heart. Reason 3 O O
99(22): Reason 3 O O
1681-4. Reason 3 O O
DOI: Reason 3 O O
10.1136/heartjnl-2013-304449 Reason 3 O O
(accessed Reason 3 O O
19 Reason 3 O O
July Reason 3 O O
2021). Reason 3 O O
- Reason 3 O O
Abbasi, Reason 3 O O
J. Reason 3 O O
2021 Reason 3 O O
Researchers Reason 3 O O
investigate Reason 3 O O
what Reason 3 O O
COVID-19 Reason 3 O O
does Reason 3 O O
to Reason 3 O O
the Reason 3 O O
